Overview

Join CarboHyde for the 11th edition of its flagship Masterclass series—an expert-led deep dive into parenteral cyclodextrin applications. This advanced, practice-oriented session explores how cyclodextrins enable safe, effective injectable formulations across small molecules and biologics, including protein therapeutics and vaccines.

The Masterclass blends scientific fundamentals, hands-on formulation strategy, and real-world case studies, addressing both opportunities and limitations while highlighting emerging directions in the field.

What You’ll Learn

  • Parenteral-grade cyclodextrins: selection criteria, quality attributes, and regulatory expectations
  • Formulation development & optimization: solubility enhancement, stability, compatibility, and excipient interactions
  • Biologics-focused insights: protein stabilization, aggregation control, vaccine formulation considerations
  • Small-molecule injectables: complexation strategies, safety margins, and performance trade-offs
  • Case studies: successes, pitfalls, and decision frameworks from development to scale-up
  • Limitations & risk management: toxicity thresholds, dosing constraints, and formulation boundaries
  • What’s next: novel derivatives, new indications, and innovation pathways

Who Should Attend?

This Masterclass is designed for professionals working in or transitioning to parenteral drug development, including:

  • Formulation Scientists & R&D Leaders (small molecules and biologics)
  • CMC, Pharmaceutical Development & Technical Operations Teams
  • Vaccine Developers & Protein Scientists
  • Drug Delivery & Enabling Technology Specialists
  • Regulatory Affairs & Quality Professionals
  • Project Managers & Decision-Makers evaluating injectable formulation strategies

Why You’ll Benefit

  • Practical, decision-ready knowledge: Move beyond theory to actionable formulation strategies
  • Cross-modality perspective: Understand how cyclodextrins behave differently with proteins, vaccines, and small molecules
  • Risk-aware development: Learn where cyclodextrins add value—and where they may not
  • Accelerated development timelines: Apply proven approaches to reduce iteration cycles
  • Future-proof insights: Stay ahead of regulatory, technological, and clinical trends

Format & Experience

  • Live, expert-led online session
  • Structured learning + applied examples
  • Interactive discussion and Q&A
  • Comprehensive takeaways you can apply immediately in development programs

Key Topics at a Glance

  • Parenteral excipient requirements
  • Cyclodextrin–API and cyclodextrin–protein interactions
  • Stability, safety, and scalability
  • Clinical and commercial considerations
  • Innovation beyond current standards

Who It’s For (In One Line)

If you develop, evaluate, or make decisions about injectable formulations—from early R&D to late-stage programs—this Masterclass is built for you.